Schonfeld Strategic Advisors LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 63 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$346,555
-83.0%
10,960
-78.1%
0.00%
-83.3%
Q2 2023$2,042,179
+47.2%
50,078
+34.5%
0.02%
+38.5%
Q1 2023$1,387,447
+12.7%
37,227
+69.4%
0.01%
+30.0%
Q3 2022$1,231,000
-47.0%
21,970
-51.1%
0.01%
-56.5%
Q2 2022$2,324,000
+33.9%
44,900
+87.9%
0.02%
+43.8%
Q1 2022$1,736,000
-54.6%
23,900
+1.3%
0.02%
-61.0%
Q2 2021$3,822,000
+120.4%
23,600
-26.0%
0.04%
+78.3%
Q4 2020$1,734,000
+688.2%
31,880
+179.1%
0.02%
+27.8%
Q4 2017$220,000
-1.3%
11,424
+9.4%
0.02%
-64.0%
Q2 2016$223,00010,4430.05%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders